Events

Dr. Anne De Groot has been invited to speak at the GTC 2nd Immunogenicity and Immunotoxicity Conference January 30-31st in San Diego, CA. This conference is one of four co-located conferences for the Novel Immunotherapeutics Summit 2014 and focuses on important progress made in the ares of therapeutic protein immunogenicity and immunotoxicity evaluation and mitigation. Learn ...

Interested in learning more about innovative technologies in vaccine development? Dr. Anne De Groot, CEO/CSO of EpiVax, will be giving a FREE webinar lecture entitled “Designing an epitope-driven vaccine for a “stealth virus” – H7N9 case study“, generously hosted by DNAvaccine.com. Her lecture will explore the principles and applications of epitope-driven vaccines, using H7N9 as a case study.  Join us on December 6th ...

EpiVax is excited to announce that we will be attending the 6th Annual Biotech Showcase in San Francisco, January 13th to 15th. We will be engaging in partnering sessions and will be featuring our own innovative technology platforms, including ISPRI for best in class protein immunogenicity screening, iVAX our web-based gene-to-vaccine design platform, and Tregitope, our novel immunomodulatory molecule. ...

EpiVax’ very own Dr. Annie De Groot is an invited speaker at the ASHI annual meeting this week. She will be providing a talk on the morning of Tuesday, November 19th,  2013 during the 39th annual meeting of American Society for Histocompatibility and Immunogenetics (ASHI) (http://www.ashi-hla.org/) to be held in Sheraton Chicago Hotel & Towers, ...

EpiVax will be attending the upcoming Immunogenicity Summit in DC. EpiVax’ BDA, Anthony Marcello, will be presenting 3 posters (see below) on behalf of the EpiVax science team. Additionally, one of EpiVax’ Tregitope collaborators, Dr. David W. Scott, will be giving an exciting talk about tolerization approaches to FVIII therapy. Posters:  Antigen-specific tolerance induction by Tregitopes in vivo Immunogenic ...

We are pleased to announce that EpiVax is hosting the “Tregitope Europe” meeting in conjunction with the 9th International Congress on Autoimmunity in Nice, France on March 26th 2014. The meeting will consist of a 120 minute scientific session as part of the main conference dedicated to research and technology for treg based immune modulation. Tregitope Europe continues ...

Dr. Annie De Groot is an invited speaker at the 6th Workshop on Monoclonal Antibodies in Basel, Switzerland, on September 12th, 2013. She will presenting information on CHO host cells proteins (HPC’s) and their effects on the immunogenicity of biologics. She will also present information regarding the CHOPPI website, a free online immunogenicity screening tool ...

Introduction: The annual Vaccine & ISV Annual Global Congress, co-organized by the Vaccine journal and the International Society for Vaccines (ISV), is the largest non-commercial conference in the vaccine field and attended by vaccine experts and researchers around the world. The journal Vaccine (http://www.journals.elsevier.com/vaccine/) is the pre-eminent journal for those interested in vaccines and vaccination.  ISV ...

4th Immunoinformatics and Computational Immunology Workshop EpiVax will be the 4th ICIW this year! We will be presenting posters and extensive iVAX and ISPRI demos. We hope to see you there. EpiVax Accepted Posters (PDF’s linked): A.S. De Groot, P. Bertino, P. Hoffman, M. Carbone, A.G. Siccardi, F. Terry, L.P. Cousens, L. Moise, and W. Martin. Highly Immunogenic ...

Registration is now open and abstracts are being accpeted, for 7th Annual Vaccine Renaissance Conference Providence, RI Registration is now open for iCubed’s seventh annual Vaccine Renaissance Conference. The conference is slated for October 16-18, 2013 in Providence, Rhode Island. Abstracts are being accepted and the deadline is September 15th – send 250 word abstract to Patrick Lowney ...

Dr. Annie De Groot will be in Japan from October 7th – 11th, to meet with collaborators and to host a semi-annual seminar on immunogenicity. The purpose of this seminar is to bridge the gap between recent academic research on Tregs, Tregitopes and protein drug development (immunogenicity, tolerance induction). Full Agenda Here – 議題 Please check this page for updates. To ...

8th Antibody Engineering and Discovery Conference – AED 2013 EpiVax’s Anthony Marcello will be attending the 8th Antibody Engineering and Discovery Conference in Boston, MA from 7/24/13 – 7/25/13. Also, we are presenting 7 posters! See below to download our posters. Location: Boston, MA – Revere Hotel, Boston Common, 200 Stuart Street Boston, MA 02116 Antigen-specific tolerance induction by Tregitopes in vivo. Tregitopes: The active ...

Measurement of Residual Host Cell Protein and DNA in Biotechnology Products Work Shop On Monday, June 3rd at 2:35 PM EpiVax’s CEO/CSO Dr. Annie De Groot presented a talk on the Immunogenicity Analysis of CHOP Contaminants in Therapeutic Protein Formulations. The workshop was hosted by USP and BEBPA, and designed specifically for the biopharmaceutical industry. The meeting ...

EpiVax was in Japan from May 8th – 15th hosting our semiannual immunogenicity seminar. The ‘Westin Immunogenicity Seminar’ was a great success. Thank you to all the wonderful speakers and attendees that made our seminar possible. We are looking forward to our following visit in the Fall, probably in late October, for our next meeting. We will keep you all up-to-date on our ...

EpiVax will be at the 11th Annual EID and Biodefense Meeting, June 17-19, 2013 at the Almas Temple Club, Washington, DC. Dr. Annie De Groot will be joining a panel of vaccine and influenza experts to discuss pandemic universal influenza vaccines. See EID and Biodefense Agenda Here Panel: Towards Universal Pandemic Influenza Vaccines Influenza has officially moved into epidemic status for 2013. Work towards ...

EpiVax will be in Sitges, Spain October 26th – 29th. We will be attending the 7th Vaccine & ISV Congress where we will be sponsoring an ‘EpiVax Welcome Cocktail Reception‘ on Sunday the 27th. Come join us for a time to connect, network and enjoy a cocktail in beautiful Sitges, Spain. We will also be attending the ...

Immunopathology of T1D & Advances in the Knowledge and Treatment of Autoimmunity – Whistler BC – April 4-9 EpiVax’s Dr. Leslie Cousens will be attending Keystone’s Immunogpathology of T1D conference this April. She will be presenting a poster depicting some fascinating data relating to T1D and Tregitopes! Check out the links below: EpiVax_T1D_Keystone_Conference_Poster_25Mar13 Poster Number: 1011 Poster Title: Application of Tregitopes for tolerance induction ...

Fourth Immunoinformatics and Computational Immunology Workshop (ICIW 2013) September 22, 2013 DoubleTree by Hilton Hotel Bethesda – Washington DC, USA, in conjunction with ACM-BCB, September 22-25, 2013 EpiVax will be making a stop in DC this September at the ICIW Workshop 2013! EpiVax’s propriety in-silico platforms embody the essence of  “Bridging Immunology and Computer Science” by enabling drug developers to design more effective vaccines and safer biologics. We hope to see you ...

Dr. Annie De Groot will be in Japan from May 8th – 15th, to meet with collaborators and host a semi-annual seminar on immunogenicity. Please see below for details. Sign Up Here! (フォームを登録) –  PDF Agenda (議題) Immunogenicity Seminar 2013 Sponsored by: The Institute for Immunology and Informatics (iCubed), University of Rhode Island & EpiVax, Inc. Venue: The Westin Tokyo – Kiri Room Thursday, May ...

SAVE THE DATE! EpiVax is hosting a cocktail reception at University of Hawaii’s new Cancer Center (at the Sullivan Center), Sunday May 5th, 5:30 – 8:30 pm! Hawaii-tope will be a cocktail and appetizer reception sponsored by EpiVax and the venue was generously donated by Dr. Michele Carbone, Director of UHCC. If you are attending the AAI conference or will be in the area, please come and ...

Tregtiope West was a great success! We would like to say ‘thank you’ to all of our speakers and to all those who attended. We had a wonderful turnout and your participation is very much appreciated. See below for a digital copy of the handouts and links to our posters. Click Here For Full Agenda Full Tregitope West Printout ...

Bioterror is the real threat. At the most recent joint US-Korea wargames, held on the border of North and South Korea, biowarfare was one of the threats introduced, to which allied forces had little to no defense. That exercise drove home the importance of biowarfare preparedness, and the military is currently scrambling to get up ...

EpiVax is attending the Immunogenicity Summit in Bethesda this week. Look for Leslie and Annie in person (Annie is usually at the microphone asking questions about HLA associations). We will be piloting some new slides on Epitope Networks. (For more on that, see the link to our CHO/Host Cell protein talk, which is also available ...

Modern Genome-Based Vaccine Design Sponsored by: EpiVax & iCubed Venue: Pacifico Yokohama: 1-1-1, Minato Mirai, Nishi-ku, Yokohama, Japan  Friday November 16th, 9:00 am – 5:00 pm Speakers: Dr. Hiroshi Kiyono M.D. Professor and Dean, Institute of Medical Science, University of Tokyo Dr. Annie De Groot M.D. Professor and Director, Institute of Immunology and Informatics, University of Rhode Island CEO/CSO, EpiVax  Dr. Takuya Tsunoda, M.D., Ph.D. President & CEO OncoTherapy Science, ...

Our Tregitope tour continues this month and on through the fall including stops in Orlando, Bethesda and Yokohama. Take a look at the list below and let us know if you’d like us to visit you while we’re in the area. ICIW 2012 Tutorial Session 10/7 – 10/10 In conjunction with: ACM International Conference on Bioinformatics and Computational ...

The Third Immunoinformatics and Computational Immunology Workshop will be held in conjunction with the ACM International Conference on Bioinformatics and Computational Biology in Orlando, FL on October 7-10 2012. The main theme of this meeting is “Bridging Immunology and Computer Science“. Nowadays computational methods are integral to virtually every research and development project in every discipline. ...

Providence-based biotech EpiVax, Inc. was awarded a new NIH SBIR Phase II grant totaling $1.5M in funding from the National Institutes of Health’s (NIH) NIDDK to explore formulation, dose, route and delivery vehicle for Tregitope through the NIH Small Business Innovation Research (SBIR) program. EpiVax anticipates receiving an additional SBIR award of approximately $775,000 within ...

The 4th Annual Tregitope update will be held in Baltimore Maryland on April 20th, 2012 (Click here for more information). Dr. Srini Kaveri of the Centre de Recherche des Cordeliers (INSERM) in Paris will provide an update on the mechanism of action of IVIG with an eye to parallels with Tregitope. A wide range ...

EpiVax is a proud sponsor of the 6th Annual Vaccine Renaissance Conference scheduled for October 15-17, 2012 in Providence, Rhode Island.

Where will we be in Spring 2012? Click here to hear about our latest research and cutting edge approaches to immunogenicity solutions. . .

The Westin Seminar is back! Join us in Tokyo on March 16th to discuss immunogenicity risk and mitigation.

Come participate in one of the following hands-on demonstrations of our bioinformatics tools!  Each of these workshops features presentations and demonstrations led by our expert immunoinformaticians. Learn from the best! Hands-on Workshops! 5th Antibody Generation, Engineering & Design Conference Frankfurt, Germany Le Meridien Parkhotel, Frankfurt, Germany 29th of February 2012 Half-Day Workshop February 29th: Latest Advances in Reducing the Risk of ...

It’s a New Year (2012) and our resolution is to keep you better informed. Here’s a list of our upcoming conferences. . . .

Westin Immunogenicity Seminar 2011 Tuesday, September 27, 2011 9:45 am – 6:10 pm Kiri Room The Westin Tokyo 1-4-1 Mita Meguro-ku, Tokyo 153-8580 Japan Speakers: Annie De Groot M.D. Director and Professor, Institute of Immunology and Informatics,University of Rhode Island and CEO/CSO EpiVax; Frances Terry, Immunoinformatics / Bioinformatics Specialist, EpiVax, Inc. Keizo Yoshida Ph.D., EpiVax Asia   9: 00 – 9 :45  AM Registration / Breakfast 9: ...

Tregitope offers an opportunity to rethink protein therapeutics, immunogenicity and tolerance. Evidence is accumulating that Tregitopes are the ‘natural off switch’, leading to suppression of inflammatory T cell responses, and modulating the phenotype of antigen presenting cells. Learn more about Tregitope by participating in the following conferences where the collective work of the Tregitope researchers ...

Come hear the latest updates on better proteins and vaccines by design – See our list of speaking engagements and appearances here:

A ‘don’t-miss’ meeting of academic researchers, immunologists, and industry scientists gathering to discuss in silico, in vitro and in vivo drivers of human immune response. The meeting is followed by a hands-on training in immunoinformatics (TRIAD Toolkit) and the annual Tregitope meeting (discussion of tolerance-inducing Tregitope).

Agenda for Immunogenicity Determinants and Correlates Conference – Valid as of March 05, 2011

Tregitopes are small peptidic regulatory T-cell epitopes derived from human immunoglobulins that activate regulatory T cells (Tregs). Tregitope therapy has broad-reaching implications, offering new treatments for autoimmune diseases (e.g. type 1 juvenile diabetes, multiple sclerosis, rheumatoid arthritis, and lupus), allergies, and transplantation rejection. In previous meetings, the members of the Tregitope Collaborators team have demonstrated ...

Immunogenicity: Determinants and Correlates is a non-commercial meeting, sponsored by the Institute for Immunology and Informatics and organized by individuals from a wide range of backgrounds including industry and academic settings. The current agenda, confirmed speakers, and the registration website are now posted for your review.

Expert immunologist and Biotech CEO Dr. Annie De Groot of EpiVax, Inc. who is also faculty member of the Brown University Medical School and Professor at the University of Rhode Island, will provide a detailed discussion of immunogenicity and tolerance for a highly selected audience. We will address the following important questions: (1) What drives the ...

SAVE THE DATE May 9, 10 and 11 1st Immunogenicity – Determinates and Correlates Providence, RI

Annie De Groot, EpiVax CEO will be speaking at the following conferences. Please click on the links for more information. We look forward to meeting you there! Invited Speaker. Regulating Immune Response in Biologics – A Paradigm- Shifting Solution. Session: Immunogenicity Issues. 2nd Annual Advancing Biologics from the Lab to the Clinic, Amsterdam, Netherlands. January 25-26, ...